Search results
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 2 days agoPhase 2 data, published in December, found that people with serious high-risk melanomas who received...
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 3 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 5 days agoIn an attempt to head off that surgery, doctors may consider another immunotherapy treatment....
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in...
WTNH-TV New Haven· 4 days agoUpon the execution of the agreement, Hanmi Pharmaceutical will conduct a phase 1 clinical trial to...
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Benzinga via Yahoo Finance· 3 days agoOn Thursday, U.S. drug maker Merck & Co Inc (NYSE:MRK) reported first-quarter sales of $15.8...
British man tests first personalised melanoma vaccine
BBC via Yahoo News· 2 days agoPhase II trial data, published in December, found that people with serious high-risk melanomas who...
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 4 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express PD-L1 (TACTI-003, Cohort B) shows ...
...Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in...
Morningstar· 5 days agoThe VERSATILE...
Man’s ‘bump on head’ turns out to be sign of skin cancer
Yahoo Life UK· 2 days agoYoung says he feels 'excited' to be trialling the new vaccine. (PA) PA Phase 2 data, published in...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...